Evaluation of Biosimilar Utilization by Hospital Types
Worked with a pharmaceutical trade organization to identify biosimilars of interest.
Worked with a pharmaceutical trade organization to identify biosimilars of interest. Biosimilars and their reference products’ utilization were totaled for each hospital by year. Analyses examined the interaction of market entry of the biosimilars, hospitals’ 340B status, teaching status, and other variables.
CEO insights
Related articles
Real analysis from people who’ve been there
Advocacy Coalition for Uptake of Comprehensive Genomic Profiling
Worked with a diverse group of industry stakeholders including diagnostics manufacturers, laboratories, academic institutions, and disease-specific advocacy groups to redefine comprehensive genomic profiling through the creation of a “new narrative”.
Physician State Society Federal and State Policy Counsel
Worked with a large physician state society on policy issues critical to medical oncologists.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.